Huge Fraud involving Aids Drugs ?

The Federal Criminal Police as well as several prosecutors would investigate several major pharmaceutical distributor, reported NDR info. This is alleged, certain discounted or repackaged for Africa 'subsidized' AIDS drugs to a large extent, brought illegally to Germany and sold here with an extremely high profits have to - the drugs were brought here in Germany usual prices on the market. The BKA Federal Criminal Police has confirmed the report of the NDR in the meantime.

In this case, the AIDS drugs, according to NDR info in part "as so-called bulk - so loose tablets in boxes and bags - illegally from South Africa to Belgium and Switzerland imported to Germany."

Overall, according to a spokesman AOK over 10,000 packages in Germany to the market. They were given to pharmacies to "unusually low" purchase price - this should have been eigenbtlich suspicious.

The financial loss estimated by the AOK should at least double-digit million range. Besides Germany, is determined in this proceeding in Switzerland, Belgium, South Africa and other countries. In Germany, prosecutors Flensburg, Lubeck Trier and are involved in the investigation against the pharmaceutical wholesaler. Is determined inter alia against a pharmaceutical wholesaler with three companies based on Sylt and against a company in Trittau.

to be flown up the fraud originally in August 2009 in a pharmacy in Delmenhorst, Lower Saxony. In a package of an AIDS drug manufacturer GlaxoSmithKline fake counterfeit packaging and leaflets had been found. This was a precaution to the recall of a batch run. Also Boehringer Ingelheim has recalled 2009 and 2010 several batches of an AIDS drug.

Since November 2010, the Trier public prosecutor is investigating a pharmaceutical company on suspicion of illegal trade in anti-AIDS drugs.

The drugs themselves should not have been falsified in their active substance (on the other hand, cited the 'Focus', however, Attorney General Günther Möller with the reference to "much lower" potency, however, "still in the range of tolerance"). The re-import and marketing in Germany was not, however, was accepted, it is said. However, it considered whether damages were caused by broken cold chain or expiry dates had expired.

In another potential danger points, the German AIDS-Help: pharmaceutical companies have the possibility of illegal re-imports in recent years repeatedly used as an argument against the tax-price their drugs for poorer countries. Now there is a risk that the reservations are growing again. The care of HIV-positive people with drugs could well become worse. Winfried Holz, DAH-board member, has also a solution: "Out of the scandal can learn something. If the pharmaceutical companies to share their preparations for the production of generic drugs, are not illegal re-export of these drugs possible"

Update
24.02.2011, 20:30: pharmaceutical company GSK called statements of NDR info as "speculation": "The report of NDR Info contains the presumption that the affected HIV drugs were determined from the House of GlaxoSmithKline for residents and that a re-import reportedly extremely high profit margins have been achieved. In the illustrations in the report is pure speculation. "GSK pointed out that" fake tablets were not found until today. " Registration owner had since October 2010, the company operated jointly with Pfizer ViiV Healthcare. We cooperate with the investigation completely.

Source: Ondamaris.de